What ails Divi’s?
Finshots Daily
00:00
Devi's Made Generic APIs and Custom Synthesis APIs
Devi's began with an ingredient for a drug called naproxen, a popular anti-inflammatory drug. It used enzymes instead of chemicals to induce a reaction from the drug faster. Pharma giants knew there was no conflict of interest, unlike other Indian pharma companies. Devi's became a star of the Indian pharma industry and its share price rocketed by a staggering 1000% between 2010 and 2020. But the last 1.5 years have not been kind to the company - shares have crashed by nearly 50%. And more recently, it's a bit dumb margins.
Play episode from 02:03
Transcript
